This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Vivos Therapeutics’s 8K filing here.
Vivos Therapeutics Company Profile
Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Read More
- Five stocks we like better than Vivos Therapeutics
- What is Short Interest? How to Use It
- David Tepper Loads Up on China—These 5 Stocks Stand Out
- 3 REITs to Buy and Hold for the Long Term
- Datadog Is in the Doghouse, But This Dip Spells Opportunity
- How to Capture the Benefits of Dividend Increases
- Vertiv Stock Under Pressure: Is Opportunity Knocking?
